Financial Ratios GoFintech Quantum Innovation Limited

Equities

290 KYG2118A1132

Investment Banking & Brokerage Services

Delayed Hong Kong S.E. Other stock markets 09:09:05 15/05/2026 BST			5-day change	1st Jan Change
8.810 ^HKD	-3.08%		+4.51%	+229.96%

05-11	GoFintech Quantum Partners With QureGenAI Biotech on Quantum Drug Discovery; Shares Gain 3%	MT
05-08	Gofintech Quantum Innovation enters MoU for strategic cooperation with Quregenai Biotech	RE

229d450282d10b9c62507ff.lq11cOPobyEFBq6aHL_je9xmRNFP_d-EmqjhS_S0du0._pssAIWlV2lCSfSuJO-GNasoD74di7v-1funer3SFdza4TlEracsGVd0mg

Published financial data: GOFINTECH QUANTUM INNOVATION LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Interest and Dividend Income, Total	35.91M	13.33M	6.86M	6.03M	17.85M
Interest Expense, Total	23.22M	11.57M	5.14M	2M	3.03M
Net Interest Income	12.69M	1.76M	1.72M	4.03M	14.82M
Brokerage Commission	47.85M	33.62M	3.61M	33.38M	18.29M
Trading and Principal Transactions	-	-	-	-	-
Asset Management Fee	9.75M	4.7M	11.03M	4.78M	3.9M
Underwriting & Investment Banking Fee	38.21M	6.84M	5.44M	4.72M	2.34M
Other Revenues, Total	-	-	-	534K	821M
Revenues Before Provison For Loan Losses	108M	46.92M	21.81M	47.45M	860M
Provision For Loan Losses	-7.12M	5.42M	16.72M	6.03M	182K
Total Revenues	116M	41.49M	5.09M	41.42M	860M
Salaries And Other Employee Benefits	66.25M	51.7M	42.58M	35.73M	70.98M
Cost of Services Provided, Total	30.55M	25.27M	6.25M	20.82M	826M
Depreciation & Amortization - (IS) - (Collected)	-	-	-	-	-
Provision for Bad Debts	1.65M	570K	-	-	-
Other Operating Expenses	48.71M	24.87M	13.68M	21.07M	27.36M
Total Operating Expenses	147M	102M	62.5M	77.62M	924M
Operating Income	-31.55M	-60.92M	-57.41M	-36.2M	-64.07M
Income (Loss) on Equity Invest.	-352K	-21K	855K	-2.48M	1.64M
Currency Exchange Gains (Loss)	-2.95M	736K	128K	-279K	-948K
Other Non Operating Income (Expenses)	5.02M	1.41M	1.94M	8.28M	12.34M
EBT, Excl. Unusual Items	-29.84M	-58.8M	-54.49M	-30.69M	-51.04M
Impairment of Goodwill	-	-3.99M	-	-	-
Gain (Loss) on Sale of Investments	18.95M	-3.15M	-4.63M	-3.48M	50.65M
Gain (Loss) on Sale of Assets	-1.19M	-	-	-	2.07M
Asset Writedown	-	-13.59M	-1M	-6.14M	-3.4M
Other Unusual Items	4.13M	-	1.26M	9.68M	-
EBT, Incl. Unusual Items	-7.94M	-79.53M	-58.86M	-30.63M	-1.73M
Income Tax Expense	5.56M	-225K	-8K	45K	799K
Earnings From Continuing Operations	-13.5M	-79.31M	-58.86M	-30.68M	-2.52M
Net Income to Company	-13.5M	-79.31M	-58.86M	-30.68M	-2.52M
Minority Interest	-	-	-	-	-
Net Income - (IS)	-13.5M	-79.31M	-58.86M	-30.68M	-2.52M
Net Income to Common Incl Extra Items	-13.5M	-79.31M	-58.86M	-30.68M	-2.52M
Net Income to Common Excl. Extra Items	-13.5M	-79.31M	-58.86M	-30.68M	-2.52M
Per Share Items
Net EPS - Basic	-0.01	-0.09	-0.06	-0.01	-0
Basic EPS - Continuing Operations	-0.01	-0.09	-0.06	-0.01	-0
Basic Weighted Average Shares Outstanding	915M	915M	1.06B	3.38B	6.67B
Net EPS - Diluted	-0.01	-0.09	-0.06	-0.01	-0
Diluted EPS - Continuing Operations	-0.01	-0.09	-0.06	-0.01	-0
Diluted Weighted Average Shares Outstanding	915M	915M	1.06B	3.38B	6.67B
Normalized Basic EPS	-0.02	-0.04	-0.03	-0.01	-0
Normalized Diluted EPS	-0.02	-0.04	-0.03	-0.01	-0
Supplemental Items
Effective Tax Rate - (Ratio)	-70.03	0.28	0.01	-0.15	-46.29
Current Domestic Taxes	5.56M	-225K	-8K	45K	97K
Total Current Taxes	5.56M	-225K	-8K	45K	97K
Total Deferred Taxes	-	-	-	-	702K
Normalized Net Income	-18.65M	-36.75M	-34.06M	-19.18M	-31.9M
Supplemental Operating Expense Items
Stock-Based Comp., Other (Total)	-	-	-	306K	39.44M
Total Stock-Based Compensation	-	-	-	306K	39.44M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	264M	190M	112M	289M	92.19M
Accounts Receivable, Total	59.51M	47.54M	30.41M	2.94M	68.16M
Other Receivables	89.78M	70.82M	15.35M	99.07M	141M
Gross Property Plant And Equipment	58.65M	26.32M	25.77M	31.25M	36.55M
Accumulated Depreciation	-36.52M	-26.32M	-25.77M	-16.62M	-28.87M
Net Property Plant And Equipment	22.13M	0	0	14.63M	7.68M
Goodwill	3.99M	-	-	-	-
Other Intangibles, Total	6.61M	6.61M	6.61M	6.61M	42.68M
Investment In Debt and Equity Securities	138K	138K	-	79.77M	285M
Trading Asset Securities, Total	101M	5.39M	71.49M	174M	301M
Restricted Cash	267M	175M	137M	277M	156M
Other Current Assets, Total	5.92M	3.08M	3.39M	22.6M	83.91M
Other Long-Term Assets, Total	135M	105M	99.85M	127M	3.43B
Total Assets	955M	605M	476M	1.09B	4.61B
Liabilities
Accounts Payable, Total	294M	179M	142M	281M	214M
Short-Term Borrowings	161M	100M	-	-	415M
Current Portion of Long-Term Debt	101M	33.01M	29.18M	2.06M	-
Current Portion of Leases	7.7M	6.79M	5.47M	7.22M	8.3M
Long-Term Debt	52.34M	30.52M	2.02M	-	-
Long-Term Leases	11.19M	4.83M	106K	14.7M	6.88M
Current Income Taxes Payable	3.32M	1.27M	834K	843K	890K
Unearned Revenue, Current	380K	419K	-	-	-
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	-	-	-	-	40.63M
Deferred Tax Liability Non-Current	-	-	-	-	702K
Total Liabilities	631M	357M	179M	305M	686M
Common Stock, Total	91.53M	91.53M	132M	633M	746M
Additional Paid In Capital	689M	689M	763M	789M	1.25B
Retained Earnings	-470M	-544M	-603M	-633M	-636M
Treasury Stock	-	-	-	-	-52.22M
Comprehensive Income and Other	13.58M	11.28M	4.9M	-1.23M	2.62B
Total Common Equity	324M	248M	296M	787M	3.93B
Minority Interest	-	-	-	-	-
Total Equity	324M	248M	296M	787M	3.93B
Total Liabilities And Equity	955M	605M	476M	1.09B	4.61B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	915M	915M	1.32B	6.33B	7.46B
ECS Total Common Shares Outstanding	915M	915M	1.32B	6.33B	7.46B
Book Value / Share	0.35	0.27	0.22	0.12	0.53
Tangible Book Value	314M	241M	290M	780M	3.88B
Tangible Book Value Per Share	0.34	0.26	0.22	0.12	0.52
Total Debt	334M	176M	36.78M	23.98M	431M
Net Debt	-31.56M	-20.2M	-146M	-439M	37.76M
Equity Method Investments, Total	104M	105M	99.65M	113M	2.99B
Full Time Employees	81	69	55	67	62

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-13.5M	-79.31M	-58.86M	-30.68M	-2.52M
Depreciation, Depletion & Amortization	21.99M	9.63M	-	1.89M	8.84M
Total Depreciation, Depletion & Amortization	21.99M	9.63M	-	1.89M	8.84M
(Gain) Loss On Sale of Asset - (CF)	1.19M	-	-	-	-2.07M
(Gain) Loss on Sale of Investments - (CF)	-18.95M	3.09M	4.63M	3.48M	-50.65M
Total Asset Writedown	-	17.59M	1M	6.14M	3.4M
Provision for Credit Losses	-7.12M	5.42M	16.72M	6.03M	182K
(Income) Loss On Equity Investments - (CF)	352K	21K	-855K	2.48M	-1.64M
Stock-Based Compensation (CF)	-	-	-	306K	39.44M
Provision and Write-off of Bad Debts	1.65M	570K	136K	-	-
Change in Trading Asset Securities	136M	93.45M	4.92M	-	-
Change in Accounts Receivable	21.98M	8.67M	5.31M	-89.42M	-157M
Change in Accounts Payable	-39.77M	-114M	-37.78M	139M	-25.98M
Change in Unearned Revenues	270K	39K	-419K	-	-
Change in Other Net Operating Assets (Collected)	40.43M	137M	86.56M	-140M	121M
Other Operating Activities	11.05M	13.1M	5.36M	-20.96M	-25.88M
Cash from Operations	155M	95.12M	26.73M	-122M	-92.99M
Capital Expenditure	-4.86M	-130K	-	-	-4.47M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-14.95M
Divestitures	-	-	-	-	2.72M
Purchase / Sale of Intangible Assets	-	-	-	-	-36M
Investment in Marketable and Equity Securities, Total	-	1.22M	-75.51M	-196M	-715M
Other Investing Activities, Total	579K	239K	1.36M	7.26M	13.8M
Cash from Investing	-4.28M	1.33M	-74.15M	-189M	-754M
Short Term Debt Issued, Total	657M	462M	200M	-	415M
Long-Term Debt Issued, Total	10M	-	-	-	-
Total Debt Issued	667M	462M	200M	-	415M
Short Term Debt Repaid, Total	-748M	-523M	-300M	-	-
Long-Term Debt Repaid, Total	-111M	-97.99M	-39.05M	-34.42M	-9.62M
Total Debt Repaid	-859M	-621M	-339M	-34.42M	-9.62M
Issuance of Common Stock	-	-	114M	527M	246M
Other Financing Activities, Total	-17.04M	-11.19M	-5.92M	-3.04M	-3.03M
Cash from Financing	-209M	-170M	-31.13M	490M	649M
Foreign Exchange Rate Adjustments	6.58M	144K	-123K	-1.93M	454K
Net Change in Cash	-51.28M	-73.43M	-78.67M	178M	-197M
Supplemental Items
Cash Interest Paid	17.04M	11.19M	5.92M	3.04M	3.03M
Cash Income Tax Paid (Refund)	17.16M	-1.99M	-1.6M	36K	-101K
Net Debt Issued / Repaid	-192M	-159M	-139M	-34.42M	406M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-1.27	-10.17	-10.9	-3.91	-0.09
Return On Equity %	-4.17	-27.72	-21.62	-5.66	-0.11
Return on Common Equity	-4.17	-27.72	-21.62	-5.66	-0.11
Margin Analysis
Gross Profit Margin %	74.7	39.89	-18.11	49.98	4
SG&A Margin	58.43	125.4	841.04	86.51	8.26
Income From Continuing Operations Margin %	-11.67	-191.14	-1.16K	-74.07	-0.29
Net Income Margin %	-11.67	-191.14	-1.16K	-74.07	-0.29
Net Avail. For Common Margin %	-11.67	-191.14	-1.16K	-74.07	-0.29
Normalized Net Income Margin	-16.13	-88.57	-669.06	-46.31	-3.71
Asset Turnover
Asset Turnover	0.11	0.05	0.01	0.05	0.3
Short Term Liquidity
Current Ratio	1.39	1.53	2.08	2.97	1.24
Quick Ratio	0.91	0.98	1.29	1.94	0.89
Operating Cash Flow to Current Liabilities	0.27	0.3	0.15	-0.42	-0.14
Long Term Solvency
Total Debt/Equity	102.84	70.85	12.4	3.05	10.97
Total Debt / Total Capital	50.7	41.47	11.04	2.96	9.88
LT Debt/Equity	19.59	14.26	0.72	1.87	0.18
Long-Term Debt / Total Capital	9.66	8.35	0.64	1.81	0.16
Total Liabilities / Total Assets	66.06	59.01	37.69	27.96	14.88
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-0.04	-64.11	-87.73	713.75	1.98K
Gross Profit, 1 Yr. Growth %	-8.72	-80.84	-105.57	-2.35K	66.06
Earnings From Cont. Operations, 1 Yr. Growth %	-81.21	487.69	-25.79	-47.87	-91.77
Net Income, 1 Yr. Growth %	-81.21	487.69	-25.79	-47.87	-91.77
Normalized Net Income, 1 Yr. Growth %	-38.85	97.07	-7.33	-43.68	66.31
Diluted EPS Before Extra, 1 Yr. Growth %	-81.22	487.72	-35.6	-83.69	-95.6
Common Equity, 1 Yr. Growth %	0.25	-23.57	19.61	165.4	398.91
Total Assets, 1 Yr. Growth %	-18.11	-36.72	-21.31	129.57	322.28
Tangible Book Value, 1 Yr. Growth %	0.25	-23.1	20.15	169.18	397.66
Cash From Operations, 1 Yr. Growth %	-1.19K	-38.67	-71.9	-657.98	-23.6
Capital Expenditures, 1 Yr. Growth %	19.33K	-97.32	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	52.78	-40.11	-79.02	-0.09	1.2K
Gross Profit, 2 Yr. CAGR %	51.98	-58.18	-89.67	11.84	510.61
Earnings From Cont. Operations, 2 Yr. CAGR %	-64.01	5.09	108.84	-37.8	-79.29
Net Income, 2 Yr. CAGR %	-64.01	5.09	108.84	-37.8	-79.29
Normalized Net Income, 2 Yr. CAGR %	-46.04	9.78	35.14	-27.75	-3.22
Diluted EPS Before Extra, 2 Yr. CAGR %	-67.31	5.06	94.55	-67.59	-91.53
Common Equity, 2 Yr. CAGR %	-10.81	-12.47	-4.39	78.17	263.89
Total Assets, 2 Yr. CAGR %	-19.8	-28.01	-29.43	34.4	211.35
Tangible Book Value, 2 Yr. CAGR %	-11.12	-12.19	-3.88	79.84	266
Cash From Operations, 2 Yr. CAGR %	-3.87	158.99	-58.48	13.12	106.47
Capital Expenditures, 2 Yr. CAGR %	-19.82	128.04	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	21.44	-5.73	-64.69	-28.98	174.71
Gross Profit, 3 Yr. CAGR %	21.11	-23.79	-78.64	-37.88	27.59
Earnings From Cont. Operations, 3 Yr. CAGR %	-40.92	-8.69	-6.42	31.49	-68.31
Net Income, 3 Yr. CAGR %	-40.92	-8.69	-6.42	31.49	-68.31
Normalized Net Income, 3 Yr. CAGR %	-18.19	-16.9	3.75	0.95	-4.61
Diluted EPS Before Extra, 3 Yr. CAGR %	-46.34	-14.37	-10.75	-14.86	-83.35
Common Equity, 3 Yr. CAGR %	-4.79	-15.29	-2.87	34.37	151.13
Total Assets, 3 Yr. CAGR %	-10.97	-25.89	-25.85	4.56	96.85
Tangible Book Value, 3 Yr. CAGR %	-5.5	-15.31	-2.52	35.49	152.48
Cash From Operations, 3 Yr. CAGR %	-7.96	-17.24	23.53	-7.76	-0.75
Capital Expenditures, 3 Yr. CAGR %	-24.35	-74.19	-	-	225.15
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	18.75	14.42	-39.83	-3.51	49.37
Gross Profit, 5 Yr. CAGR %	20.83	10.62	-54.75	-11.15	-18.33
Earnings From Cont. Operations, 5 Yr. CAGR %	-20.57	20.74	-2.1	-21.69	-48.81
Net Income, 5 Yr. CAGR %	-20.43	20.74	-2.1	-21.69	-48.81
Normalized Net Income, 5 Yr. CAGR %	-6.73	3.6	-0	-21.43	0.91
Diluted EPS Before Extra, 5 Yr. CAGR %	-34.68	0.48	-10.17	-41.95	-65.21
Common Equity, 5 Yr. CAGR %	24.44	-2.25	-4.63	14.05	64.74
Total Assets, 5 Yr. CAGR %	15.84	-9.37	-18.87	-5.97	31.64
Tangible Book Value, 5 Yr. CAGR %	24.55	-2.49	-4.86	14.46	65.48
Cash From Operations, 5 Yr. CAGR %	32.91	-18.13	-33.06	-6.22	45.66
Capital Expenditures, 5 Yr. CAGR %	26.03	-44.48	-	-	182.13